ATE429447T1 - Aufreinigung von her-2-varianten - Google Patents
Aufreinigung von her-2-variantenInfo
- Publication number
- ATE429447T1 ATE429447T1 AT04738948T AT04738948T ATE429447T1 AT E429447 T1 ATE429447 T1 AT E429447T1 AT 04738948 T AT04738948 T AT 04738948T AT 04738948 T AT04738948 T AT 04738948T AT E429447 T1 ATE429447 T1 AT E429447T1
- Authority
- AT
- Austria
- Prior art keywords
- purification
- provides
- chromatography
- variant
- variants
- Prior art date
Links
- 238000000746 purification Methods 0.000 title abstract 3
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 title abstract 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 3
- 238000005571 anion exchange chromatography Methods 0.000 abstract 2
- 238000001597 immobilized metal affinity chromatography Methods 0.000 abstract 2
- 238000001542 size-exclusion chromatography Methods 0.000 abstract 2
- 241000238631 Hexapoda Species 0.000 abstract 1
- 238000011026 diafiltration Methods 0.000 abstract 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 abstract 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001103—Receptors for growth factors
- A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48231503P | 2003-06-25 | 2003-06-25 | |
| DKPA200300954 | 2003-06-25 | ||
| PCT/DK2004/000451 WO2004113377A1 (en) | 2003-06-25 | 2004-06-24 | Purification of her-2 variants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE429447T1 true ATE429447T1 (de) | 2009-05-15 |
Family
ID=33542436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04738948T ATE429447T1 (de) | 2003-06-25 | 2004-06-24 | Aufreinigung von her-2-varianten |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP1641819B1 (de) |
| JP (1) | JP4579912B2 (de) |
| AT (1) | ATE429447T1 (de) |
| AU (1) | AU2004249362B2 (de) |
| CA (1) | CA2530233C (de) |
| DE (1) | DE602004020769D1 (de) |
| DK (1) | DK1641819T3 (de) |
| ES (1) | ES2325584T3 (de) |
| MX (1) | MXPA05013389A (de) |
| NO (1) | NO20055948L (de) |
| NZ (1) | NZ544017A (de) |
| WO (1) | WO2004113377A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060033870A (ko) | 2003-06-25 | 2006-04-20 | 파멕사 에이/에스 | Ｈｅｒ-2 변이체의 정제 |
| US20080253993A1 (en) * | 2005-03-31 | 2008-10-16 | Pharmexa A/S | Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope |
| NZ575388A (en) * | 2006-10-06 | 2012-03-30 | Bn Immunotherapeutics Inc | Recombinant modified vaccinia ankara encoding a her-2 antigen and a taxane for use in treating cancer |
| ES2991988T3 (es) | 2017-10-30 | 2024-12-05 | Takeda Pharmaceuticals Co | Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica |
| JP2023542867A (ja) * | 2020-09-11 | 2023-10-12 | グリンプス バイオ， インコーポレイテッド | 疾患の検出／診断、病期分類、モニタリング及び処置のための生体外でのプロテアーゼ活性検出 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080409A (en) * | 1995-12-28 | 2000-06-27 | Dendreon Corporation | Immunostimulatory method |
| DE69918146T2 (de) | 1998-10-05 | 2005-07-07 | Pharmexa A/S | Verfahren zur therapeutischen impfung |
| IL144371A0 (en) * | 1999-01-29 | 2002-05-23 | Corixa Corp | Her-2/neu fusion proteins |
| US20030228606A1 (en) * | 2002-04-11 | 2003-12-11 | Amgen Inc., A Corporation Of The State Of Delaware | Her-2 receptor tyrosine kinase molecules and uses thereof |
-
2004
- 2004-06-24 DE DE602004020769T patent/DE602004020769D1/de not_active Expired - Lifetime
- 2004-06-24 AU AU2004249362A patent/AU2004249362B2/en not_active Ceased
- 2004-06-24 WO PCT/DK2004/000451 patent/WO2004113377A1/en not_active Ceased
- 2004-06-24 ES ES04738948T patent/ES2325584T3/es not_active Expired - Lifetime
- 2004-06-24 MX MXPA05013389A patent/MXPA05013389A/es unknown
- 2004-06-24 NZ NZ544017A patent/NZ544017A/en not_active IP Right Cessation
- 2004-06-24 EP EP04738948A patent/EP1641819B1/de not_active Expired - Lifetime
- 2004-06-24 AT AT04738948T patent/ATE429447T1/de active
- 2004-06-24 JP JP2006515732A patent/JP4579912B2/ja not_active Expired - Fee Related
- 2004-06-24 CA CA2530233A patent/CA2530233C/en not_active Expired - Fee Related
- 2004-06-24 DK DK04738948T patent/DK1641819T3/da active
- 2004-06-24 EP EP09005519A patent/EP2090586A1/de not_active Withdrawn
-
2005
- 2005-12-14 NO NO20055948A patent/NO20055948L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2090586A1 (de) | 2009-08-19 |
| WO2004113377A1 (en) | 2004-12-29 |
| DE602004020769D1 (de) | 2009-06-04 |
| NO20055948L (no) | 2005-12-14 |
| EP1641819A1 (de) | 2006-04-05 |
| NZ544017A (en) | 2008-04-30 |
| CA2530233A1 (en) | 2004-12-29 |
| MXPA05013389A (es) | 2006-03-17 |
| JP4579912B2 (ja) | 2010-11-10 |
| CA2530233C (en) | 2012-09-11 |
| JP2007523615A (ja) | 2007-08-23 |
| DK1641819T3 (da) | 2009-08-03 |
| AU2004249362B2 (en) | 2011-08-25 |
| AU2004249362A1 (en) | 2004-12-29 |
| ES2325584T3 (es) | 2009-09-09 |
| EP1641819B1 (de) | 2009-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3805248A3 (de) | Prozess, um antikörper und therapeutische produkte zu konzentrieren | |
| WO2003062375A3 (en) | Stabilizing polypeptides which have been exposed to urea | |
| EA200700917A1 (ru) | Способ рефолдинга рекомбинантных антител | |
| WO2002069232A3 (en) | Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity | |
| CY1109715T1 (el) | IL-1β ΔΕΣΜΕΥΤΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ΚΑΙ ΘΡΑΥΣΜΑΤΑ ΑΥΤΩΝ | |
| WO2006041934A3 (en) | Methods and compositions for improving recombinant protein production | |
| AU2003215188A1 (en) | Fusion proteins of humanized g250 specific antibodies and uses thereof | |
| WO2008013454A3 (en) | Immunogenic compounds and protein mimics | |
| WO2005111066A8 (en) | Polypeptides from non-typeable haemophilus influenzae | |
| ATE551352T1 (de) | Peptidakzeptorbindungsverfahren | |
| WO2000056901A3 (en) | Linear and circular expression elements | |
| EP1365025A4 (de) | Agarase und gen dafür | |
| WO2006053021A3 (en) | Methods for engineering polypeptide variants via somatic hypermutation and polypeptides made thereby | |
| ATE429447T1 (de) | Aufreinigung von her-2-varianten | |
| EA200600102A1 (ru) | Очистка вариантов her-2 | |
| WO2003016904A3 (en) | Peptide sequence tags and method of using same | |
| WO2002062964A3 (en) | Ap1 amine oxidase variants | |
| WO2002077648A3 (en) | Pathogenic and commensal vaccine antigens | |
| WO2002063009A8 (en) | Lp mammalian proteins; related reagents | |
| WO2005003289A3 (en) | Ap1 amine oxidase variants | |
| ATE353105T1 (de) | Methode zur erhöhung der effizienz von enzymatischen aufreinigungsprozessen | |
| ATE381576T1 (de) | Verfahren zur aufreinigung eines n-terminalen fragments des hepatozytenwachstumsfaktors | |
| DE60334078D1 (de) | Organische anionentransporter-proteine (oatp/lst) und ihre dna | |
| WO2003048320A3 (en) | Novel motor protein of p. falciparum and methods for its use | |
| UA42436A (uk) | Спосіб виробництва альбуміну бичачого сироваткового (бса) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1641819 Country of ref document: EP |